In gastric cancer, macrophage-derived CXCL5 promotes tumor cell migration through the CXCR2/STAT3 pathway [27] and facilitates chemoresistance via the CXCL5/PI3K/AKT/mTOR pathway [42]. This evidence concerns the gene STAT3 and neoplasm.